Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
135. Israili Z.H., Hall W.D. Cough and angioneurotic edema, associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology // Ann. Intern. Med. -1992.-Vol. 117.-P. 234.
136. Bush R.K. et al. Prevalence of sensitivity to sulfiting agents in asthmatic patients // Am. J. Med. -
1986.-Vol. 81.-P. 816.
14-4567
417
137. Goldfarb G., Simon R.A. Provocation of sulfite sensitive asthma 11 J. Allergy Clin. Immunol. -1984.-Vol. 73.-P. 135.
138. Simon R.A., Stevenson D.D. Lack of cross sensitivity between aspirin and sulfite in sensitive asthmatics 11 Ibid. - 1987. - Vol. 79. - P. 257.
139. Pisani R.J., Rosenow E.C. 3rd. Drug-induced pulmonary disease // Current Pulmonology / Eds.
D.H. Simmons, D.F. Tierney. Vol 13. - St. Louis: Mosby Year-Book, 1992. - P. 311.
140. Hoimberg L. et al. Adverse reactions to nitrofurantoin. Analysis of 921 reports // Am. J. Med. -
1980.-Vol. 69.-P. 733.
141. Sostman H.D. etal. Methotrexate-induced pneumonitis// Medicine. - 1976. - Vol. 55. - P. 371.
142. Martin W.J. 2nd, Rosenow E.C. 3rd. Amiodarone pulmonary toxicity. Pt. 1 // Chest. - 1988. -Vol. 93.-P. 1067.
143. Kennedy J.L. Clinical aspects of amiodarone pulmonary toxicity // Clin. Chest Med. - 1990. -Vol. 11.-P. 119.
144. Manicardi V. et al. Low-dose amiodarone-induced pneumonitis: evidence of an immunologic pathogenic mechanism // Am. J. Med. - 1989. - Vol. 86. - P. 134.
145. Kennedy J.L. et al. Amiodarone pulmonary toxicity: clinical, radiologic, and pathologic correlations // Arch. Intern. Med. - 1987. - Vol. 147. - P. 50.
146. Evans R.B. etal. Gold lung: recent developments in pathogenesis, diagnosis and therapy // Semin. Arthritis Rheum. - 1987. - Vol. 16. - P. 196.
147. Cooper J.A.D.Jr. etal. Drug-induced pulmonary disease. Pt 1: Cytotoxic drugs 11 Am. Rev. Respir. Dis. - 1986.-Vol. 133.-P. 321.
148. Holoye P. et al. Bleomycin hypersensitivity pneumonitis 11 Ann. Intern. Med. - 1978. - Vol. 88. -P. 47.
149. Kavaru M.S. et al. Hydrochlorothiazide-induced acute pulmonary edema 11 Cleve. Clin. J. Med. -1990.-Vol. 57.-P. 181.
150. Kline J.N., Hirasuna J.D. Pulmonary edema after freehase cocaine smoking-not due to an adulterant // Chest. - 1990. - Vol. 97. - P. 1009.
151. Brashear R.E. Effects of heroin, morphine, methadone and propoxyphene on the lung // Semin. Respir. Med. - 1980. - Vol. 2. - P. 59.
152. Heffner J.E., Sahn S.A. Salicylate-induced pulmonary edema: clinical features and prognosis // Ann. Intern. Med. - 1981. - Vol. 95. - P. 405.
153. Andersson B.S. etal. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia // Cancer. - 1990. - Vol. 65. - P. 1079.
154. Spry C.J.F. Eosinophilia and allergic reactions to drugs // Clin. Haematol. - 1980. - Vol. 9. -P. 521.
155. Davis P. Significance of eosinophilia during gold therapy // Arthritis Rheum. - 1974. - Vol. 17. -P. 964.
156. Stafford B.T., Crosby W.H. Late onset of gold-induced thrombocytopenia // JAMA. - 1978. -Vol. 239. - P. 50.
157. Shulman N.R. A mechanism of cell destruction in individuals sensitized to foreign antigens and its implications in autoimmunity // Ann. Intern. Med. - 1964. - Vol. 60. - P. 506.
158. Strieker R.B., Shuman M.A. Quinidine purpura: evidence that glycoprotein V is a target platelet antigen // Blood. - 1986. - Vol. 67. - P. 1377.
159. Chong B.H. Heparin-induced thrombocytopenia // Blood Rev. - 1988. - Vol. 2. - P. 108.
160. Chong B.H. et al. Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172 // Blood. - 1989. - Vol. 73. - P. 1592.
161. SalamaA., Mueller-Eckhardt C. On the mechanisms of sensitization and attachment of antibodies to RBC in drug-induced immune hemolytic anemia // Ibid. - 1987. - Vol. 69. - P. 1006.
162. Swanson M.A. etal. Immunohemolytic anemia due to antipenicillin antibodies // N. Engl. J. Med. -
1966.-Vol. 274.-P. 178.
418
163. Worlledge S.M. etal. Autoimmune hemolytic anemia associated with alpha-methyldopa therapy // Lancet. - 1966. - Vol. 2. - P. 135.
164. Vincent P.C. Drug-induced aplastic anemia and agranulocytosis incidence and mechanisms // Drugs. - 1986. - Vol. 31. - P. 52.
165. Young G.A.R., Vincent P.C. Drug-induced agranulocytosis // Clin. Haematol. - 1980. - Vol. 3. -P. 483.
166. Willson R.A. The liver: its role in drug biotransformation and as a target of immunologic injury // Immunol. Allergy Clin. North Am. - 1991. - Vol. 11. - P. 555.
167. Lewis J.H., Zimmerman H.J. Drug-induced liver disease // Med. Clin. North Am. - 1989. -Vol. 73. - P. 775.
168. Black M. Acetaminophen hepatoloxicity // Annu. Rev. Med. - 1984. - Vol. 34. - P. 577.
169. Zimmerman H.J., Lewis J.H. Drug-induced cholestasis 11 Med. Toxicol. - 1987. - Vol. 2. - P. 112.
170. Mitchell J.R. etal. Isoniazid liver injury: Clinical spectrum, pathology and probable pathogenesis I I Ann. Intern. Med. - 1976. - Vol. 84. - P. 181.
171. Kenna J.G. et al. Evidence for expression in human liver of halothane induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis // Hepatology. - 1988. -Vol. 8.-P. 1635.
